Top Markets
Coin of the day
Health Sciences Group, Inc. Health Sciences Group, Inc.

Health Sciences Group, Inc.

HESG
주식 순위 #37259
Operating through its various subsidiaries, Health Sciences Group Inc. (HESG)... Operating through its various subsidiaries, Health Sciences Group Inc. (HESG) specializes in supplying a range of ingredients and finished products for the nutritional supplement and functional food and beverage sectors across the United States. Key among its offerings is Shugr, an innovative, calorie-free sugar alternative meticulously formulated to replicate the taste and baking properties of traditional cane sugar. Another notable product is the Sequesterol Advance Cardio Formula, a proprietary blend featuring clinically validated ingredients designed to support robust cardiovascular well-being and maintain optimal blood circulation. The company's portfolio further includes Aplevia, an antioxidant extracted from apple peels, and Edible Sponges, an open-cell hydrocolloid product. Distribution channels for these products are diverse, encompassing major retail chains — such as mass merchandisers, pharmacies, grocery stores, and discount outlets — alongside sales to healthcare professionals, practitioners, and various other media platforms. Tracing its origins to 1996 as Centurion Properties Development Corporation, the company underwent a name change to iGoHealthy.com in 2000, before adopting its current designation, Health Sciences Group, Inc., in 2001. Its corporate headquarters are situated in Newport Beach, California.
주가
$0.0001
마지막 동기화: 2026-08-13
시가총액
$1.87M
변동 (1일)
0.00%
변동 (1년)
9,900.00%
국가
US
거래 Health Sciences Group, Inc. (HESG)

카테고리

Health Sciences Group, Inc. (HESG)의 매출
Aug 2026 기준 매출 TTM: 0
Health Sciences Group, Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Health Sciences Group, Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
$12.62B -
US
$6.02B -
NL
- -
CH
- -
KR
$10.11B -
BE